These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9234335)

  • 21. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography.
    Wahl RL; Hutchins GD; Buchsbaum DJ; Liebert M; Grossman HB; Fisher S
    Cancer; 1991 Mar; 67(6):1544-50. PubMed ID: 2001543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Robotic production of 2-deoxy-2-[18F]fluoro-D-glucose: a routine method of synthesis using tetrabutylammonium [18F]fluoride.
    Brodack JW; Dence CS; Kilbourn MR; Welch MJ
    Int J Rad Appl Instrum A; 1988; 39(7):699-703. PubMed ID: 2844702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
    Lucignani G; Paolini G; Landoni C; Zuccari M; Paganelli G; Galli L; Di Credico G; Vanoli G; Rossetti C; Mariani MA
    Eur J Nucl Med; 1992; 19(10):874-81. PubMed ID: 1451704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absorbed dose estimates in positron emission tomography studies based on the administration of 18F-labeled radiopharmaceuticals.
    Mejia AA; Nakamura T; Itoh M; Hatazawa J; Ishiwata K; Ido T; Matsumoto M; Watabe H; Watanuki S; Seo S
    J Radiat Res; 1991 Sep; 32(3):243-61. PubMed ID: 1838773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of myocardial glucose utilization of hypertrophic and dilated cardiomyopathy using 18F-2-fluoro 2-deoxy-D-glucose and positron emission tomography].
    Ohtake T; Kosaka N; Watanabe T; Momose T; Nishikawa J; Sasaki Y; Iio M; Yokoyama I; Iizuka M; Sugimoto T
    Nihon Rinsho; 1991 Jan; 49(1):143-7. PubMed ID: 2002593
    [No Abstract]   [Full Text] [Related]  

  • 27. 2-Deoxy-2-fluoro-D-glucose as a functional probe for NMR: the unique metabolism beyond its 6-phosphate.
    Kanazawa Y; Yamane H; Shinohara S; Kuribayashi S; Momozono Y; Yamato Y; Kojima M; Masuda K
    J Neurochem; 1996 May; 66(5):2113-20. PubMed ID: 8780043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
    Ishikawa M; Kikuchi H; Nagata I; Yamagata S; Taki W; Yonekura Y; Nishizawa S; Iwasaki Y; Mukai T
    Neurol Med Chir (Tokyo); 1990 Jun; 30(6):377-81. PubMed ID: 1700316
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wilson's disease studied with FDG and positron emission tomography.
    Hawkins RA; Mazziotta JC; Phelps ME
    Neurology; 1987 Nov; 37(11):1707-11. PubMed ID: 3499583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
    Katzenellenbogen JA; Welch MJ; Dehdashti F
    Anticancer Res; 1997; 17(3B):1573-6. PubMed ID: 9179196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [18F]fluoride from a small cyclotron for the routine synthesis of [18F]2-fluoro-2-deoxy-D-glucose.
    Dejesus OT; Martin JA; Yasillo NJ; Gatley SJ; Cooper MD
    Int J Rad Appl Instrum A; 1986; 37(5):397-401. PubMed ID: 3019942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cortical hypometabolism and its recovery following nucleus basalis lesions in baboons: a PET study.
    Kiyosawa M; Pappata S; Duverger D; Riche D; Cambon H; Mazoyer B; Samson Y; Crouzel C; Naquet R; MacKenzie ET
    J Cereb Blood Flow Metab; 1987 Dec; 7(6):812-7. PubMed ID: 3500958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FDG-PET evaluation of retroperitoneal metastases of testicular cancer before and after chemotherapy.
    Reinhardt MJ; Müller-Mattheis VG; Gerharz CD; Vosberg HR; Ackermann R; Müller-Gärtner HW
    J Nucl Med; 1997 Jan; 38(1):99-101. PubMed ID: 8998160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regional distribution of 2-deoxy-2[18F]-fluoro-D-glucose for metabolic imaging using positron emission tomography.
    Alagona P; Hart DT; Eikman EA
    Int J Card Imaging; 1994 Jun; 10(2):137-43. PubMed ID: 7963752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiopharmaceuticals for positron emission tomography. Development of new, innovative tracers for measuring the rates of physiologic and biochemical processes.
    Gatley SJ; DeGrado TR; Kornguth ML; Holden JE
    Acta Radiol Suppl; 1990; 374():7-11. PubMed ID: 1966972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of 2-[18F]fluoro-2-deoxyglucose as a potential agent in the prediction of graft rejection by positron emission tomography.
    Heelan BT; Osman S; Blyth A; Schnorr L; Jones T; George AJ
    Transplantation; 1998 Oct; 66(8):1101-3. PubMed ID: 9808498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PET FDG studies in oncology.
    Hawkins RA; Hoh CK
    Nucl Med Biol; 1994 Jul; 21(5):739-47. PubMed ID: 9241650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET 2-fluoro-2-deoxyglucose uptake in rat prostate adenocarcinoma during chemotherapy with gemcitabine.
    Haberkorn U; Bellemann ME; Altmann A; Gerlach L; Morr I; Oberdorfer F; Brix G; Doll J; Blatter J; van Kaick G
    J Nucl Med; 1997 Aug; 38(8):1215-21. PubMed ID: 9255154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-stationary spatial filtering and accelerated curve fitting for parametric imaging with dynamic PET.
    Herholz K
    Eur J Nucl Med; 1988; 14(9-10):477-84. PubMed ID: 3265103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Validity of positron emission tomography (PET) using 2-deoxy-2-[18F]fluoro-D-glucose (FDG) in patients with renal cell carcinoma (preliminary report)].
    Kawamura J; Hida S; Yoshida O; Yonekura Y; Senda M; Yamamoto K; Saji H; Fujita T; Konishi J
    Kaku Igaku; 1988 Oct; 25(10):1143-8. PubMed ID: 3265450
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.